ANIK
- NASDAQ - DRUGS - Biotechnology
Anika Therapeutics Inc
|
$41.64 |
+0.44
1.07%
|
$41.78
|
$45.35
|
-8.18% |
41,650 28.72%
|
145,000
|
Most Recent Note for ANIK - 11/27/2015 11:00:49 AM
Consolidating in a tight range near its 52-week high since last noted with caution in the 11/13/15 mid-day report after volume-driven gains - "Reported earnings +38% on +7% sales revenues for the Sep '15 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings (negative) growth."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BFAM
- NASDAQ - DIVERSIFIED SERVICES - Personal Services
Bright Horizns Fam Solns
|
$68.77 |
+0.19
0.28%
|
$68.90
|
$69.09
|
-0.46% |
68,549 34.62%
|
198,000
|
Most Recent Note for BFAM - 11/27/2015 11:02:19 AM
Reported earnings +34% on +9% sales revenues for the Sep '15 quarter, but fundamental concerns remain. Rallying to new highs after completing another Secondary Offering on 11/19/15 while consolidating near its 50 DMA line. Completed Secondary Offerings on 8/11/15 and on 5/29/15. Noted with caution in prior mid-day reports - "Not match with the fundamental guidelines (C criteria) of the fact-based investment system. Completed another Secondary Offering on 12/11/14, and earlier Secondary Offerings on 3/26/14 and 6/12/13."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BNK
- NYSE - BANKING - Regional - Southeast Banks
C 1 Financial Inc
|
$24.20 |
+0.03
0.12%
|
$24.23
|
$24.49
|
-1.18% |
15,858 36.04%
|
44,000
|
Most Recent Note for BNK - 11/27/2015 11:02:34 AM
Holding its ground since gapping up on 11/10/15 for a new 52-week high on M&A news. Prior mid-day reports cautioned members - "Reported earnings +72% on +26% sales revenues for the Sep '15 quarter, and showed strong sales revenues and earnings increases in the Mar and Jun '15 quarters. Fundamental concerns remain because its annual earnings (A criteria) history has not been strong and steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CBPO
- NASDAQ - DRUGS - Biotechnology
China Biologic Products
|
$125.66 |
+5.78
4.82%
|
$126.00
|
$128.00
|
-1.83% |
56,367 32.03%
|
176,000
|
Most Recent Note for CBPO - 11/27/2015 11:03:24 AM
Challenging its 52-week high. Prior mid-day reports repeatedly cautioned members - "This Chinese Biomed firm completed new Public Offerings on 6/10/15 and 6/27/14. Reported +16% earnings on +14% sales revenues for the Sep '15 quarter, below the +25% minimum (C criteria). Following a downturn in FY '10 earnings its annual earnings (A criteria) have been improving."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CRM
- NYSE - INTERNET - Internet Software & Services
Salesforce.com Inc
|
$79.83 |
-0.58 -0.72%
|
$80.48
|
$82.90
|
-3.70% |
982,020 25.91%
|
3,790,000
|
Most Recent Note for CRM - 11/27/2015 11:04:59 AM
Holding its ground at new 52-week and all-time highs following volume-driven gains. Earnings rose +50% on +24% sales revenues for the Oct '15 quarter, its 6th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). Found support at its 50 DMA line during its consolidation since noted in the 10/13/15 mid-day report with caution - "Downturn in FY '14 was noted as a flaw in its annual earnings (A criteria) history. It survived but failed to impress since 10/06/10 when this Computer Software -Enterprise firm was dropped from the Featured Stocks list."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CUBI
- NASDAQ - Banks-Northeast
Customers Bancorp Inc
|
$30.54 |
-0.31 -1.00%
|
$30.82
|
$31.63
|
-3.45% |
57,196 35.97%
|
159,000
|
Most Recent Note for CUBI - 11/27/2015 11:08:57 AM
Consolidating in a tight range near its high. Through Sep '15 its quarterly and annual earnings history (C and A criteria) has not been a match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EBS
- NYSE - DRUGS - Biotechnology
Emergent Biosolutions
|
$38.51 |
+0.20
0.52%
|
$38.68
|
$38.98
|
-1.21% |
128,340 37.64%
|
341,000
|
Most Recent Note for EBS - 11/27/2015 11:10:37 AM
Perched at its all-time high with no resistance remaining due to overhead supply. Recently rallied above prior highs in the $36 area. Prior mid-day reports repeatedly cautioned members - "The 2 latest quarterly comparisons through Sep '15 showed improved sales revenues and earnings increases. Prior quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FXCB
- NASDAQ - Finance-Savings & Loan
Fox Chase Bancorp Inc
|
$18.19 |
+0.03
0.17%
|
$18.19
|
$18.27
|
-0.44% |
6,673 30.33%
|
22,000
|
Most Recent Note for FXCB - 11/27/2015 11:12:23 AM
Found support near its 50 DMA line the recently rallied to new highs. Fundamental concerns remain. Prior mid-day reports cautioned members - "Quarterly earnings (C criteria) history and sub par sales revenues growth rate are not a match with the fact-based investment system's guidelines. "
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HALL
- NASDAQ - INSURANCE - Property & Casualty Insurance
Hallmark Financial Svcs
|
$12.46 |
-0.04 -0.32%
|
$12.50
|
$13.29
|
-6.25% |
8,856 27.68%
|
32,000
|
Most Recent Note for HALL - 11/27/2015 11:15:43 AM
Found support at its 50 DMA line after noted with caution in recent mid-day reports - "Reported earnings +94% on +15% sales revenues for the Sep '15 quarter, its second strong quarterly earnings improvement. Prior quarterly sales revenues and earnings have not been strong and steady, and its annual earnings history included a drastic downturn from FY '09 and a loss on FY '11."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HD
- NYSE - RETAIL - Home Improvement Stores
Home Depot Inc
|
$135.29 |
+0.64
0.48%
|
$135.35
|
$135.24
|
0.04% |
1,310,840 25.29%
|
5,183,000
|
Most Recent Note for HD - 11/27/2015 11:17:36 AM
Perched at all-time highs following 8 consecutive gains marked by volume. Recent mid-day reports cautioned members - "Found prompt support at its 50 DMA line. Reported earnings +18% on +6% sales revenues for the Oct '15 quarter, and prior quarters were not strong and steady above the +25% minimum earnings guideline (C criteria). Has a new CEO as of 11/03/14. Sales revenues increases in quarterly comparisons versus the year ago periods have not been especially strong, revealing no great demand for new (N criteria) products or services. Annual earnings (A criteria) increases have been improving after a downturn in FY '08 - FY '10."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HRL
- NYSE - FOOD & BEVERAGE - Meat Products
Hormel Foods Co
|
$74.36 |
+0.81
1.09%
|
$74.46
|
$73.97
|
0.52% |
382,017 35.40%
|
1,079,000
|
Most Recent Note for HRL - 11/27/2015 11:19:26 AM
Hitting new 52-week highs with today's 4th consecutive gain. The 11/25/15 mid-day report cautioned members - "Quarterly earnings history (C criteria) through Oct '15 has been below the +25% minimum guideline of the fact-based investment system. Sales revenues decelerated from slow growth to negative comparisons in the Jul and Oct quarters versus year ago periods, respectively."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IRMD
- NASDAQ - Medical-Systems/Equip
Iradimed Corp
|
$32.28 |
+0.52
1.64%
|
$32.54
|
$33.25
|
-2.92% |
22,247 30.90%
|
72,000
|
Most Recent Note for IRMD - 11/27/2015 11:22:57 AM
Challenging its 52-week high with gains this week. Found support near prior highs during its consolidation after rallying from the previously noted flat base. Prior mid-day reports cautioned members - "Reported strong quarterly sales revenues and earnings increases above the +25% minimum guideline (C criteria) in the 3 latest comparisons through the Sep '15 quarter. Quarterly revenues have been below $10 million, and while growing, they remain rather minuscule. Limited history is a concern while up considerably from its $6 IPO in July '14."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LGIH
- NASDAQ - Bldg-Resident/Comml
L G I Homes Inc
|
$32.93 |
+0.03
0.10%
|
$33.03
|
$33.87
|
-2.76% |
144,948 28.42%
|
510,000
|
Most Recent Note for LGIH - 11/27/2015 11:24:21 AM
Perched within close striking distance of its 52-week high after finding support above its 50 DMA line again recently, still building an orderly base. Reported Sep '15 earnings +124% on +88% sales revenues, showing solid sales revenues acceleration while also marking the 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). The Building - Residential / Commercial firm has a limited history since its IPO at $11 on 11/07/13.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MKL
- NYSE - INSURANCE - Property & Casualty Insurance
Markel Corp
|
$918.61 |
+3.62
0.40%
|
$924.89
|
$937.91
|
-2.06% |
18,642 34.52%
|
54,000
|
Most Recent Note for MKL - 11/27/2015 11:25:07 AM
Holding its ground near its 52-week high following an impressive streak of volume-driven gains. Prior mid-day reports repeatedly cautioned members - "Prior quarterly and annual earnings (C and A criteria) and sub par sales revenues history is below the fact-based investment system's fundamental guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NTES
- NASDAQ - INTERNET - Internet Information Providers
Netease Inc Adr
|
$161.01 |
-8.42 -4.97%
|
$167.85
|
$170.37
|
-5.49% |
706,587 79.84%
|
885,000
|
Most Recent Note for NTES - 11/27/2015 11:26:10 AM
Pulling back today after rallying to new 52-week and all-time highs with an impressive streak of 7 consecutive volume-driven gain. Prior mid-day reports repeatedly cautioned members - "Reported earnings +56% on +107% sales revenues for the Sep '15 quarter. Prior quarters had earnings increases below the +25% minimum guideline (C criteria). Annual earnings growth has been strong while it made gradual progress since dropped from the Featured Stocks list on 7/17/12."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OLED
- NASDAQ - Elec-Misc Products
Universal Display Corp
|
$54.23 |
+2.28
4.39%
|
$55.50
|
$55.83
|
-2.87% |
866,376 147.09%
|
589,000
|
Most Recent Note for OLED - 11/27/2015 11:27:36 AM
Challenging its 52-week high with a recent spurt of volume-driven gains, Prior mid-day reports cautioned members - "Sales and earnings history has been erratic. Fundamentals are not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OPB
- NASDAQ - BANKING - Regional - Pacific Banks
Opus Bank
|
$40.41 |
+0.95
2.41%
|
$40.63
|
$41.49
|
-2.60% |
47,840 26.29%
|
182,000
|
Most Recent Note for OPB - 11/27/2015 11:28:24 AM
Rebounded above its 50 DMA line and it is perched near its 52-week high. Completed a Secondary Offering on 11/17/15. Showed great sales and earnings increases in the Jun and Sep '15 quarters, however prior mid-day reports cautioned members- "Quarterly earnings history has not been strong and steady, making it not a good match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SFL
- NYSE - TRANSPORTATION - Shipping
Ship Finance Intl Ltd
|
$17.74 |
+0.30
1.72%
|
$17.76
|
$17.67
|
0.40% |
206,154 29.12%
|
708,000
|
Most Recent Note for SFL - 11/27/2015 11:31:12 AM
Hitting a new 52-week high with today's 3rd consecutive gain, but it faces additional resistance due to overhead supply. Earnings improved in the Jun and Sep '15 quarters but its prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TIS
- AMEX - CONSUMER NON-DURABLES - Paper &; Paper Products
Orchids Paper Products
|
$30.62 |
+0.09
0.29%
|
$30.62
|
$32.00
|
-4.31% |
13,260 25.50%
|
52,000
|
Most Recent Note for TIS - 11/27/2015 11:34:27 AM
Consolidating in an orderly fashion above its 50 DMA line and near its 52-week high with volume-totals cooling in recent weeks. Its quarterly and annual earnings (C and A criteria) history has not been strong and steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WSFS
- NASDAQ - BANKING - Regional - Mid-Atlantic Banks
W S F S Financial Corp
|
$33.51 |
-0.47 -1.38%
|
$34.20
|
$34.34
|
-2.42% |
39,617 40.02%
|
99,000
|
Most Recent Note for WSFS - 11/27/2015 11:38:16 AM
Holding its ground perched at all-time highs. Reported earnings +29% on +9% sales revenues for the Sep '15 quarter, but prior earnings increases were below the +25% minimum guideline (C criteria). Lackluster sales revenues growth shows no great demand for new (N criteria) products or services.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
XRS
- NYSE - Consumer Svcs-Education
T A L Education Gp A Ads
|
$43.55 |
+0.32
0.74%
|
$43.72
|
$43.49
|
0.14% |
337,377 59.92%
|
563,000
|
Most Recent Note for XRS - 11/27/2015 11:39:58 AM
Inching to another new 52-week high with today's 6th consecutive gain. Prior mid-day reports repeatedly cautioned members - "Reported +100% earnings on +42% sales revenues for the Aug '15 quarter, but the prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). This Chinese firm in the Consumer Services - Education industry group deeply undercut its 200 DMA line during its consolidation then rebounded near all-time highs since noted with caution in the 4/28/15 mid-day report. Fundamental concerns remain. Downturn in FY '13 earnings is a flaw concerning its annual earnings history (A criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|